Structural specificities ofiris tissues in the vertebrate eye

脊椎动物眼睛虹膜组织的结构特异性

基本信息

  • 批准号:
    09470003
  • 负责人:
  • 金额:
    $ 2.5万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

1. Monoclonal antibodies against chick iris and ciliary body :Iris and ciliary bodies with their appendages were dissected from chick eye balls and were processed for rainsing of monoclonal antibody according to the method developed in our laboratory (ref. Exp Eye Res 67,1998).A variety of antibodies were produced in the mice used for the study. Staining patterns were categorized into 14. Among the antibodies raised, 9 antibodies were established as monoclonal antibodies. Their characterisation is being analyzed.2. Overview of vessels in the iris :Arterioles, venules and capillaries were found in the iris stroma. Among them, capillaries were most easily identified and frequently encountered. The capillaries had unfenestrated endothelial cells, between which were sealed with tight junctions. Capillary endothelial cells were surrounded with thick basal lamina and thick collagen fibriles.3. On the permeability of endothelial cells in ciliary muscles and iris of monkey :Capillary endothelial cells in the ciliary muscles are structually different from those of the ciliary processes in that they are unfenestrated. From this point of view, both ciliary muscles and iris endothelial cells were used to study the permeability of horse radish peroxidase(HRP)to the unfenestrated endothelial cells. In brief, HRP injected into the anterior chamber entered the iris stroma, cell bodies of endothelial cells and into the lumen of capillaries in 15 min. On the contrary, HRP injected into the venular system stayed in the capillary lumen and the cell bodies even after 30min. This result is consistent with results reported so far.
1.抗鸡虹膜和睫状体的单克隆抗体:从鸡眼球中分离虹膜和睫状体及其附属物,按照本实验室开发的方法(参考文献Exp Eye Res 67,1998)进行单克隆抗体的制备。染色模式分为14种。在所产生的抗体中,9个抗体被确定为单克隆抗体。分析了它们的特征。虹膜血管概况:虹膜基质中可见小动脉、小静脉和毛细血管。其中,毛细血管最容易识别,也是最常见的。毛细血管有无窗孔的内皮细胞,它们之间由紧密连接密封。毛细血管内皮细胞被较厚的基膜和胶原纤维所包围.关于猴睫状肌和虹膜内皮细胞通透性的研究:睫状肌和睫状突的毛细血管内皮细胞结构不同,它们是无孔的。从这个角度出发,我们用睫状肌和虹膜内皮细胞来研究辣根过氧化物酶(HRP)对无孔内皮细胞的通透性。总之,前房注射HRP 15min后即进入虹膜基质、内皮细胞胞体及毛细血管腔,而微静脉系统注射HRP 30min后仍停留在毛细血管腔及胞体内。这一结果与迄今为止报告的结果一致。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIROSAWA Kazushige其他文献

HIROSAWA Kazushige的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIROSAWA Kazushige', 18)}}的其他基金

The Structure and Function of Retinal Pigment Epithelial Cells
视网膜色素上皮细胞的结构和功能
  • 批准号:
    07457003
  • 财政年份:
    1995
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development and differentiation of retinal pigment epithelial cells.
视网膜色素上皮细胞的发育和分化。
  • 批准号:
    63570006
  • 财政年份:
    1988
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
Electron Microscopic Study on the Vitamin A-Storing Cells
维生素 A 储存细胞的电子显微镜研究
  • 批准号:
    61440023
  • 财政年份:
    1986
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
  • 批准号:
    10892414
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
  • 批准号:
    10932479
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
  • 批准号:
    10674274
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
  • 批准号:
    10761372
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
  • 批准号:
    10711469
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
  • 批准号:
    10933280
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
  • 批准号:
    10696698
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
  • 批准号:
    10726173
  • 财政年份:
    2023
  • 资助金额:
    $ 2.5万
  • 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
  • 批准号:
    2212947
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
  • 批准号:
    22K19387
  • 财政年份:
    2022
  • 资助金额:
    $ 2.5万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了